Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis
Clinical trial NCT00691145 · COMPLETED
Trial details
- NCT number
- NCT00691145
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2005-02-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.